Abstract
BackgroundNICE guidance states that cognitive behavioural therapy (CBT) should be offered to all patients with psychosis. However, there is a need to improve access to therapeutic interventions. We aim to train frontline mental health staff to deliver brief, structured CBT-based therapies. We have developed and piloted a manualized intervention to support people with psychosis and anxious avoidance or depression to work towards a personal recovery goal.Methods/DesignThe ‘GOALS Study’ is a pilot randomized controlled trial comparing usual care plus an 8-week intervention with usual care alone. The key objective is to assess clinical feasibility (recruitment and randomization; compliance with the treatment manual; acceptability and satisfaction; progress towards goals). A secondary objective is a preliminary evaluation of efficacy. Sixty-six participants with a diagnosis of psychosis, plus symptoms of depression or anxiety will be recruited from adult mental health services. Those currently refusing medication, in receipt of CBT, or with a primary diagnosis of an organic mental health problem or substance dependency will be excluded. Following informed consent, randomization will be independent of the trial team, at a 50:50 ratio, at the level of the individual and stratified by main problem focus. Following randomization, participants allocated to the intervention group will begin the 8-week intervention with a local, trained member of staff, supervised by the study coordinator. Outcomes will be assessed blind to treatment condition at 0, 12 and 18 weeks post-randomization. The primary outcome measure for the efficacy analysis will be activity levels at 12 weeks. Secondary outcome measures include mood, psychotic symptoms, quality of life and clinical distress. A health economic analysis comparing service use in each condition will also be performed. Recruitment began in March, 2013 and is ongoing until December, 2014.DiscussionThis is the first trial of the GOALS intervention. The approach is brief and staff can be readily trained in its delivery: there is therefore potential to develop a cost-effective intervention that could be widely disseminated. If the trial proves clinically feasible and demonstrates preliminary evidence of efficacy, a large multi-site trial will be warranted.Trial registrationCurrent Controlled Trials ISRCTN: 73188383. http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID=13538
Highlights
National Institute for Health and Care Excellence (NICE) guidance states that cognitive behavioural therapy (CBT) should be offered to all patients with psychosis
Little evidence is available regarding their efficacy in this group. Based on these evidence-based methods, we have developed a new intervention designed to help people meet valued, personal goals and improve recovery, which can be delivered by frontline mental health staff as part of the team’s package of care
Potential participants with a diagnosis of psychosis and who are identified by their clinical team as having problems in daily functioning owing to anxiety-related avoidance or depression will be invited to learn more about the study
Summary
NICE guidance states that cognitive behavioural therapy (CBT) should be offered to all patients with psychosis. There is evidence for an increased prevalence of anxiety and depression in people with psychosis, in comparison with the general population [3,4]. These difficulties can prevent people from engaging in meaningful activity and from achieving valued goals. New cognitive behavioural approaches for psychosis have been developed to focus on recovery-oriented outcomes, such as increased activity levels and hopefulness about the future [8]. Given the large number of patients with psychosis and the limited availability of CBT-trained professionals, there is a need to consider ways of improving access
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have